(Q34997074)

5 August 2017

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score (English)

1 reference

5 August 2017

0 references

20

Alberto Ascherio

1 reference

5 August 2017

21

David A Hafler

1 reference

5 August 2017

22

Elizabeth W Karlson

1 reference

5 August 2017

0 references

1

Philip L De Jager

1 reference

5 August 2017

2

Lori B Chibnik

1 reference

5 August 2017

Jing Cui

3

1 reference

5 August 2017

Joachim Reischl

4

1 reference

5 August 2017

Stephan Lehr

5

1 reference

5 August 2017

K Claire Simon

6

1 reference

5 August 2017

Cristin Aubin

7

1 reference

5 August 2017

David Bauer

8

1 reference

5 August 2017

Jürgen F Heubach

9

1 reference

5 August 2017

Rupert Sandbrink

10

1 reference

5 August 2017

Michaela Tyblova

11

1 reference

5 August 2017

Petra Lelkova

12

1 reference

5 August 2017

Steering committee of the BENEFIT study

13

1 reference

5 August 2017

Steering committee of the BEYOND study

14

1 reference

5 August 2017

Steering committee of the LTF study

15

1 reference

5 August 2017

Steering committee of the CCR1 study

16

1 reference

5 August 2017

Eva Havrdova

17

1 reference

5 August 2017

Christoph Pohl

18

1 reference

5 August 2017

Dana Horakova

19

1 reference

5 August 2017

29 October 2009

1 reference

5 August 2017

1 reference

5 August 2017

8

1 reference

5 August 2017

12

1 reference

5 August 2017

1111-1119

1 reference

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Immunomodulatory treatment strategies in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Epidemiology of multiple sclerosis: from risk factors to prevention

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Prediction of Coronary Heart Disease Using Risk Factor Categories

8 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

8 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

Blockade of chemokine signaling in patients with multiple sclerosis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099419

EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19879194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970275-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S1474-4422(09)70275-3

1 reference

5 August 2017

1 reference

5 August 2017

1 reference